RELATED STUDY

Efficacy and safety of therapeutic use of cannabis derivatives and their synthetic analogs: Overview of systematic reviews

Key Findings:  This systematic review found moderate evidence that cannabidiol improves for the quality of life but increases the risk of adverse events in ulcerative colitis, and cannabinoids in general appear to reduce chemotherapy-related nausea and vomiting. Cannabinoids do not however appear to have clinical benefit for chronic non-oncologic pain, spasticity-related pain in multiple sclerosis, or for acute post-operative pain.